Adaptive Biotechnologies Corp (NAS:ADPT)
$ 6.145 -0.235 (-3.68%) Market Cap: 941.56 Mil Enterprise Value: 838.75 Mil PE Ratio: 0 PB Ratio: 4.20 GF Score: 81/100

Q4 2023 Adaptive Biotechnologies Corp Earnings Call Transcript

Feb 14, 2024 / 09:30PM GMT
Release Date Price: $3.94 (+8.84%)
Operator

Thanks for standing by and welcome to the Adaptive Biotechnologies fourth quarter and full year 2023 earnings conference call. (Operator Instructions) As a reminder, today's program is being recorded. And now, I'd like to introduce your host for today's program, Karina Calzadilla, Head of Investor Relations. Please go ahead.

Karina Calzadilla
Adaptive Biotechnologies Corp - Vice President - Investor Relations

Thank you, Jonathan, and good afternoon, everyone. I would like to welcome you to Adaptive Biotechnologies fourth quarter and full year '23 earnings conference call. Earlier today, we issued a press release reporting Adaptive financial results for the fourth quarter and full year of '23. The press release is available at www.adaptivebiotech.com. We are conducting a live webcast of this call and will be referencing to a slide presentation that has been posted in the Investors section on our corporate website.

During the call, management will be making projections and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot